Overactive bladder: a better understanding of pathophysiology, diagnosis and management.
about
Clinical utility of neurostimulation devices in the treatment of overactive bladder: current perspectives.The surgical management of the refractory overactive bladder.Postmenopausal overactive bladderBladder, bowel, and sexual dysfunction in Parkinson's diseaseProtein kinase C modulates frequency of micturition and non-voiding contractions in the urinary bladder via neuronal and myogenic mechanisms.The relationship between irritable bowel syndrome, functional dyspepsia, chronic fatigue and overactive bladder syndrome: a controlled study 6 years after acute gastrointestinal infectionDifferential role of opioid receptors in tibial nerve inhibition of nociceptive and nonnociceptive bladder reflexes in cats.Safety and efficacy of a patient-controlled bladder management system for treating urinary retention in men.Beyond the lower urinary tract: the association of urologic and sexual symptoms with common illnesses.NS309 decreases rat detrusor smooth muscle membrane potential and phasic contractions by activating SK3 channels.Adverse Events of Intravesical OnabotulinumtoxinA Injection between Patients with Overactive Bladder and Interstitial Cystitis--Different Mechanisms of Action of Botox on Bladder Dysfunction?Prevalence of overactive bladder syndrome (OABS) among women with gynaecological problems and its risk factors in a tertiary hospital, Negeri Sembilan, Malaysia: Implication for primary healthcare providersInvolvement of opioid receptors in inhibition of bladder overactivity induced by foot stimulation in catsDementia and lower urinary dysfunction: with a reference to anticholinergic use in elderly population.Activation of bitter taste receptors (tas2rs) relaxes detrusor smooth muscle and suppresses overactive bladder symptomsExpert Panel Recommendations on Lower Urinary Tract Health of Women Across Their Life Span.Efficacy and safety of solifenacin succinate 10 mg once Daily: A multicenter, phase III, randomized, double-blind, placebo-controlled, parallel-group trial in patients with overactive bladder.Urogynecological conditions associated with overactive bladder symptoms in women.Insight into new potential targets for the treatment of overactive bladder and detrusor overactivity.Intradetrusor injection of botulinum toxin for the management of refractory overactive bladder syndrome: an update.What are the barriers and how do we manage them? A review of progress over the last 10 years.Bladder function of patients with Parkinson's disease.Does altered myogenic activity contribute to OAB symptoms from detrusor overactivity? ICI-RS 2013.Advanced therapeutic directions to treat the underactive bladder.Reproduction of Female Lower Urinary Tract Symptoms on Urodynamics.Antimuscarinic Use in Females With Overactive Bladder Syndrome Increases the Risk of Depressive Disorder: A 3-Year Follow-up Study.Overactive bladder in children.Pharmacotherapy for Pediatric Neurogenic Bladder.Is there any Relationship Between Bladder Trabeculation and Efficacy and Safety of Intravesical Botulinum Toxin A Injection in Refractory Idiopathic Overactive Bladder Women?Interventions do not enhance medication persistence and compliance in patients with overactive bladder: a 24 weeks, randomised, open-label, multi-center trial.Urgency and other lower urinary tract symptoms in men aged ≥ 40 years: a Belgian epidemiological survey using the ICIQ-MLUTS questionnaire.A novel metered dose transdermal spray formulation for oxybutynin.Mechanisms of inhibitory action of TRK-130 (Naltalimide), a μ-opioid receptor partial agonist, on the micturition reflex.Overactive bladder symptoms, stress urinary incontinence and associated bother in women aged 40 and above; a Belgian epidemiological survey.Effects of Rho-kinase inhibition on myosin light chain phosphorylation and obstruction-induced detrusor overactivity.On the origin of spontaneous activity in the bladder.No Increased Risk of Fracture in Patients Receiving Antimuscarinics for Overactive Bladder Syndrome: A Retrospective Cohort Study.Long-term Persistence with Mirabegron versus Solifenacin in Women with Overactive Bladder: Prospective, Randomized Trial.Extending the rationale of combination therapy to unresponsive erectile dysfunction.Efficacy of adding behavioural treatment or antimuscarinic drug therapy to α-blocker therapy in men with nocturia.
P2860
Q33768707-3940E445-8AAE-4370-BE4E-B24A754532D6Q34124059-C2171BB7-AEA9-4006-8BEA-D819D2C9E9FBQ35157329-46B9AB62-0C90-4F05-A962-51C05B444FEFQ35209869-95B3C102-6707-4098-BAE8-E58B24F4598FQ35532350-9194171A-0519-4104-AD2B-C2F60436CC3EQ35658695-8A6DB0A0-0CDD-4914-A5BF-783CC9A6CFF8Q35994509-95316F04-75D2-439B-AA17-9141FD7EA399Q36161744-7188E9A7-A954-47D7-A08E-D7457801B694Q36676598-C9482DE3-DA21-4857-839D-D8536691DEFEQ36709228-BF84700C-2A56-48AA-9AFF-2A16366D21DEQ36735590-DEF8114A-F4CB-4747-AC50-2537B657F505Q36783635-C4ECE6B9-F65F-49D7-8E85-4C3B49121989Q36948182-96A36AA8-5F20-45A9-83EA-179CD7EBAD6AQ37222701-6402F2CC-3106-452D-AC03-50FF64E33AF2Q37225238-B34C5120-C38F-42B6-BF31-A9458793338EQ37424934-0D735189-A1E5-492B-8C61-BE9863A364F5Q37672836-5E9C7CEC-85E3-4F18-A09A-4E16D1294810Q37720755-EF306AD0-6675-4A3B-9CD8-28EFC23D7AAFQ38022106-F4DE132D-8BE4-4C8B-A1B4-30B4877C6D5CQ38042228-831CDAB8-8FB1-4DA2-BF14-AE60FD094CF0Q38187655-28D6C108-B40A-4165-BB5B-923AEDC7FE3BQ38191267-3FE2371D-8205-4D8C-B0C8-E33170EE4E63Q38212576-86A39302-828A-48D6-AD70-4DEECB04A72DQ38252669-FC7A1928-1035-4918-8846-DC908EA382FCQ38671573-4E46872E-1F02-4498-BB30-49C22739E96BQ38853682-65F7A596-886F-46EF-A5FC-BD7ED3FF4508Q38928932-C0EEC71B-DCED-4403-9D56-A64F77B5F38AQ39437361-E08F3F5D-92C2-44AA-ACC0-B9C611DD68DEQ40047417-90596E42-F53D-41BE-9367-1366BE955C04Q40691097-16236C98-4821-4C36-9C53-86359DEAB380Q41484409-7FF51155-FB57-4743-A78A-D238328CB9E3Q41985423-7D26DD14-1F96-42A8-B739-317FA01A18D5Q44342688-44E1DB02-329B-4302-9793-B8056D2DA78FQ44712127-3A446865-8BAF-4AF9-8283-16B6FA2A96DDQ46686515-6D37DFE7-0A93-4973-AC5B-B66AC0C07CB8Q46892861-21E3E2B6-E27D-4FED-AF50-478A46CAEBECQ47189750-A062B200-2A29-45AC-904C-61B520A6128BQ47928119-F11ECAC7-4288-4E05-AD11-96B90CCDCCF2Q47953479-3A315291-A211-46D9-A3CA-B3273F68DE70Q48508331-40A45B80-A5CD-4021-925C-D686A1CE1E00
P2860
Overactive bladder: a better understanding of pathophysiology, diagnosis and management.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Overactive bladder: a better understanding of pathophysiology, diagnosis and management.
@ast
Overactive bladder: a better understanding of pathophysiology, diagnosis and management.
@en
type
label
Overactive bladder: a better understanding of pathophysiology, diagnosis and management.
@ast
Overactive bladder: a better understanding of pathophysiology, diagnosis and management.
@en
prefLabel
Overactive bladder: a better understanding of pathophysiology, diagnosis and management.
@ast
Overactive bladder: a better understanding of pathophysiology, diagnosis and management.
@en
P1476
Overactive bladder: a better understanding of pathophysiology, diagnosis and management.
@en
P2093
Raymond R Rackley
P356
10.1016/S0022-5347(05)00313-7
P407
P433
P50
P577
2006-03-01T00:00:00Z